Get started
Author

Amit Arvind Joharapurkar

Observed names: A. Joharapurkar, Amit A Joharapurkar, Amit A. Joharapurkar, Amit Joharapurkar, Joharapurkar, Amit
ORCID: 0000-0003-0723-4371
Observed ORCID: 0000-0003-0723-4371
OpenAlex ID: A5070752590
Prolyl Hydroxylase Inhibitors: A Breakthrough in the Therapy of Anemia Associated with Chronic Diseases
2018 · Amit A. Joharapurkar, Vrajesh B. Pandya, et al. · Journal of Medicinal Chemistry · 173
Age-related changes in hematological and biochemical profiles of Wistar rats
2024 · Suresh Patel, Satish Patel, et al. · Laboratory Animal Research · 117
PDF
Antinociceptive activity of alcoholic extract of Hemidesmus indicus R.Br. in mice
2005 · Prashant R. Verma, Amit A. Joharapurkar, et al. · Journal of Ethnopharmacology · 109
Pathophysiological Mechanism of Bone Loss in Type 2 Diabetes Involves Inverse Regulation of Osteoblast Function by PGC-1α and Skeletal Muscle Atrogenes: AdipoR1 as a Potential Target for Reversing Diabetes-Induced Osteopenia
2015 · Mohd. Parvez Khan, Abhishek Kumar Singh, et al. · Diabetes · 73
In vivo evaluation of antioxidant activity of alcoholic extract of Rubia Cordifolia Linn. and its influence on ethanol-induced immunosuppression
2003 · Amit Joharapurkar, Shitalkumar Zambad, et al. · Indian Journal of Pharmacology · 72
Effect of GLP-1 Based Therapies on Diabetic Dyslipidemia
2014 · Vishal Patel, Amit Joharapurkar, et al. · Current Diabetes Reviews · 70
Diaryl Dihydropyrazole-3-carboxamides with Significant In Vivo Antiobesity Activity Related to CB1 Receptor Antagonism: Synthesis, Biological Evaluation, and Molecular Modeling in the Homology Model
2007 · Brijesh Kumar Srivastava,*, Amit Joharapurkar, et al. · Journal of Medicinal Chemistry · 63
Role of mineralocorticoid receptor antagonists in kidney diseases
2020 · Vishal Patel, Amit Joharapurkar, et al. · Drug Development Research · 62
Selective Thyromimetics Using Receptor and Tissue Selectivity Approaches: Prospects for Dyslipidemia
2012 · Amit A. Joharapurkar, Vipin V. Dhote, et al. · Journal of Medicinal Chemistry · 59
Inhibition of the methionine aminopeptidase 2 enzyme for the treatment of obesity
2014 · Amit Joharapurkar, Mukul Jain, et al. · Diabetes Metabolic Syndrome and Obesity · 57
PDF
Orally Active Osteoanabolic Agent GTDF Binds to Adiponectin Receptors, With a Preference for AdipoR1, Induces Adiponectin-Associated Signaling, and Improves Metabolic Health in a Rodent Model of Diabetes
2014 · Abhishek Kumar Singh, Amit Arvind Joharapurkar, et al. · Diabetes · 44
Discovery of potent, selective and orally bioavailable triaryl-sulfonamide based PTP1B inhibitors
2011 · Dipam Patel, Mukul Jain, et al. · Bioorganic & Medicinal Chemistry Letters · 44
Coagonist of GLP-1 and Glucagon Receptor Ameliorates Development of Non-Alcoholic Fatty Liver Disease
2018 · Vishal Patel, Amit Joharapurkar, et al. · Cardiovascular & Hematological Agents in Medicinal Chemistry · 39
Optimization of 1,2,5‐Thiadiazole Carbamates as Potent and Selective ABHD6 Inhibitors
2014 · Jayendra Z. Patel, Tapio J. Nevalainen, et al. · ChemMedChem · 38
Exendin-4 reduces glycemia by increasing liver glucokinase activity: an insulin independent effect
2012 · Nirav Dhanesha, Amit Joharapurkar, et al. · Pharmacological Reports · 34
Co-agonist of glucagon and GLP-1 reduces cholesterol and improves insulin sensitivity independent of its effect on appetite and body weight in diet-induced obese C57 mice
2013 · Vishal Patel, Amit Joharapurkar, et al. · Canadian Journal of Physiology and Pharmacology · 33
11β-Hydroxysteroid dehydrogenase type 1: potential therapeutic target for metabolic syndrome
2012 · Amit Joharapurkar, Nirav Dhanesha, et al. · Pharmacological Reports · 33
Effect of dual PPAR-α/γ agonist saroglitazar on diabetic retinopathy and oxygen-induced retinopathy
2021 · Amit Joharapurkar, Vishal Patel, et al. · European Journal of Pharmacology · 31
Combination of omeprazole with GLP-1 agonist therapy improves insulin sensitivity and antioxidant activity in liver in type 1 diabetic mice
2013 · Vishal Patel, Amit Joharapurkar, et al. · Pharmacological Reports · 28
Pyrogallol: A novel tool for screening immunomodulators
2004 · Amit Joharapurkar, Manish Wanjari, et al. · Bioline International (Bioline International) · 28
PDF
Coagonist of GLP-1 and glucagon decreases liver inflammation and atherosclerosis in dyslipidemic condition
2018 · Vishal Patel, Amit Joharapurkar, et al. · Chemico-Biological Interactions · 27
Pharmacological Characterization of ZYAN1, a Novel Prolyl Hydroxylase Inhibitor for the Treatment of Anemia
2015 · M. Jain, A. Joharapurkar, et al. · Drug Research · 27
Long-acting peptidomimetics based DPP-IV inhibitors
2012 · Pradip Jadav, Rajesh Bahekar, et al. · Bioorganic & Medicinal Chemistry Letters · 27
Inhibition of microsomal triglyceride transfer protein improves insulin sensitivity and reduces atherogenic risk in Zucker fatty rats
2011 · Vipin Dhote, Amit Joharapurkar, et al. · Clinical and Experimental Pharmacology and Physiology · 27
Discovery of Orally Active, Potent, and Selective Benzotriazole‐Based PTP1B Inhibitors
2011 · Dipam Patel, Mukul Jain, et al. · ChemMedChem · 26
Works count: 91
Citation count: 1,873
H-index: 26
I10-index: 49
Year
Topic
Type